Recent progress toward an enterotoxigenic Escherichia coli vaccine (Q38006998)

26 August 2017

Recent progress toward an enterotoxigenic Escherichia coli vaccine (English)

1 reference

enterotoxigenic Escherichia coli

26 August 2017

1 reference

1 reference

1

Ann-Mari Svennerholm

1 reference

26 August 2017

Anna Lundgren

2

1 reference

26 August 2017

1 April 2012

1 reference

Expert Review of Vaccines

26 August 2017

1 reference

26 August 2017

11

1 reference

26 August 2017

4

1 reference

26 August 2017

495-507

1 reference

Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention

26 August 2017

1 reference

Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea

21 January 2018

1 reference

Colonization factors of human enterotoxigenic Escherichia coli (ETEC).

21 January 2018

1 reference

Vaccines against enterotoxigenic Escherichia coli

21 January 2018

1 reference

Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease

21 January 2018

1 reference

21 January 2018

1 reference

Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico

21 January 2018

1 reference

Clinical characteristics and etiology of travelers' diarrhea among Korean travelers visiting South-East Asia

21 January 2018

1 reference

Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children.

21 January 2018

1 reference

Phenotypic and genotypic analysis of enterotoxigenic Escherichia coli in samples obtained from Egyptian children presenting to referral hospitals

21 January 2018

1 reference

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression

21 January 2018

1 reference

Evolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli

21 January 2018

1 reference

Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelers

21 January 2018

1 reference

Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors.

21 January 2018

1 reference

Development of multiplex PCR assays for detection of enterotoxigenic Escherichia coli colonization factors and toxins

21 January 2018

1 reference

A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation

21 January 2018

1 reference

Vaccination strategies to combat an infectious globe: oral cholera vaccines.

21 January 2018

1 reference

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

21 January 2018

1 reference

Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target

21 January 2018

1 reference

Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh

21 January 2018

1 reference

Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines

21 January 2018

1 reference

Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model.

21 January 2018

1 reference

Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins

21 January 2018

1 reference

Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children

21 January 2018

1 reference

Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

21 January 2018

1 reference

Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.

21 January 2018

1 reference

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group

21 January 2018

1 reference

Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults

21 January 2018

1 reference

Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods

21 January 2018

1 reference

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.

21 January 2018

1 reference

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers

21 January 2018

1 reference

Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea

21 January 2018

1 reference

Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study.

21 January 2018

1 reference

Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh

21 January 2018

1 reference

Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.

21 January 2018

1 reference

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

21 January 2018

1 reference

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

21 January 2018

1 reference

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

21 January 2018

1 reference

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

21 January 2018

1 reference

Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers

21 January 2018

1 reference

Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

21 January 2018

1 reference

Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice

21 January 2018

1 reference

Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

21 January 2018

1 reference

Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae

21 January 2018

1 reference

Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6.

21 January 2018

1 reference

Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.

21 January 2018

1 reference

Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.

21 January 2018

1 reference

Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.

21 January 2018

1 reference

Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model

21 January 2018

1 reference

Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.

21 January 2018

1 reference

Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.12

1 reference

26 August 2017

1 reference

PubMed ID

22551034